Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 10, 2004, Pages 3789-3793

  Marimón, José M ^a   Gomáriz, María ^a   Zigorraga, Carmen ^b   Cilla, Gustavo ^a   Pérez Trallero, Emilio ^a,c  

^a HOSPITAL DONOSTIA   (Spain)

^b Laboratorio Normativo de Salud Pública   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; FOOD; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; SEROTYPE; SPAIN;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FECES; FOOD MICROBIOLOGY; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; QUINOLONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SPAIN;

EID: 4644306539     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.10.3789-3793.2004     Document Type: Article

References (27)

1. Aarestrup, F. M., C. Wiuff, K. Molbak, and E. J. Threlfall. 2003. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47:827-829.
2. Breuil, J., A. Brisabois, I. Casin, L. Armand-Lefèvre, S. Frémy, and E. Collatz. 2000. Antibiotic resistance in salmonellae isolated from humans and animals in France: comparative data from 1994 and 1997. J. Antimicrob. Chemother. 46:965-971.
3. Cruchaga, S., A. Echeita, A. Aladuena, J. Garcia-Pena, N. Frias, and M. A. Usera. 1998. Antimicrobial resistance in salmonellae from humans, food and animals in Spain in 1998. J. Antimicrob. Chemother. 47:315-321.
4. Gensberg, K., J. F. Jin, and L. J. V. Piddock. 1995. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium. FEMS Microbiol. Lett. 132:57-60.
5. Giraud, E., A. Brisabois, J.-L. Martel, and E. Chaslus-Dancla. 1999. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43:2131-2137.
6. Giraud, E., A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla. 2000. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44:1223-1228.
7. Guerra, B., B. Malorny, A. Schroeter, and R. Helmuth. 2003. Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany. Antimicrob. Agents Chemother. 47:2059.
8. Hakanen, A., A. Siitonen, P. Kotilainen, and P. Huovinen. 1999. Increasing fluoroquinolone resistance in Salmonella serotypes in Finland during 1995-1997. J. Antimicrob. Chemother. 43:145-148.
9. Hansen, H., and P. Heisig. 2003. Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro. Microb. Drug Resist. 9:25-32.
10. Herikstad, H., P. Hayes, M. Mokhtar, M. L. Fracaro, E. J. Threlfall, and F. J. Angulo. 1997. Emerging quinolone-resistant Salmonella in the United States. Emerg. Infect. Dis. 3:371-372.
11. Laconcha, I., D. L. Baggesen, A. Rementeria, and J. Garaizar. 2000. Genotypic characterisation by PFGE of Salmonella enterica serotype Enteritidis phage types 1, 4, 6, and 8 isolated from animal and human sources in three European countries. Vet. Microbiol. 75:155-165.
12. Marimón, J. M., E. Perez-Trallero, M. Gomariz, C. Rodriguez-Andres, and C. Lopez-Lopategui. 2003. Salmonella enteric infections in Gipuzkoa, Spain, 1983-2000. Euro Surveill. 8:50-54.
13. Miller, S. I., and D. A. Pegues. 1999. Salmonella species, including Salmonella typhi, p. 2344-2363. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5th ed. Churchill Livingstone, Philadelphia, Pa.
14. Molbak, K., P. Gerner-Smidt, and H. C. Wegener. 2002. Increasing quinolone resistance in Salmonella enterica serotype Enteritidis. Emerg. Infect. Dis. 8:514-515.
15. Nakaya, H., A. Yasuhara, K. Yoshimura, Y. Oshihoi, H. Izumiya, and H. Watanabe. 2003. Life-threatening infantile diarrhea from fluoroquinolone- resistant Salmonella enterics typhimurium with mutations in both gyrA and parC. Emerg. Infect. Dis. 9:255-257.
16. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing, 14th informational supplement. Document M100-S14. NCCLS, Wayne, Pa.
17. Oteo, J., B. Aracil, J. I. Alos, and J. L. Gomez-Garces. 2000. High rate of resistance to nalidixic acid in Salmonella enterica: its role as a marker of resistance to fluoroquinolones. Clin. Microbiol. Infect. 6:273-276.
18. Piddock, L. J. V., K. Whale, and R. Wise. 1990. Quinolone resistance in Salmonella: clinical experience. Lancet 335:1459.
19. Perez-Trallero, E., M. Urbieta, C. L. Lopategui, C. Zigorraga, and I. Ayestaran. 1993. Antibiotics in veterinary medicine and public health. Lancet 342:1371-1372.
20. Popoff, M. Y., and L. Le Minor. 1997. Antigenic formulas of the Salmonella serovars. W.H.O. Collaborating Centre for Reference and Research on Salmonella, Institute Pasteur, Paris, France.
21. Prats, G., B. Mirelis, T. Llovet, C. Muñoz, E. Miró, and F. Navarro. 2000. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob. Agents Chemother. 44:1140-1145.
22. Reid, T. M. S. 1992. The treatment of non-typhi salmonellosis. J. Antimicrob. Chemother. 29:4-8.
23. Serai, C., L. López, F. J. Castillo, A. Clavel, and M. C. Rubio. 1998. Quinolone resistance in Salmonella enterica. Rev. Esp. Quimioter. 11:43-46.
24. Thompson, R. B., and J. M. Miller. 2003. Specimen collection, transport and processing: bacteriology, p. 286-330. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.). Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.
25. Threlfall, E. J., L. R. Ward, and B. Rowe. 1999. Resistance to ciprofloxacin in non-typhoidal salmonellas from humans in England and Wales - the current situation. Clin. Microbiol. Infect. 5:130-134.
26. Threlfall, E. J., I. S. Fisher, C. Berghold, P. Gerner-Smidt, H. Tschape, M. Cormican, I. Luzzi, F. Schnieder, W. Wannet, J. Machado, and G. Edwards. 2003. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro. Surveill. 8:41-45.
27. Vasallo, F. J., P. Martín-Rabadán, L. Alcalá, J. M. García-Lechuz, M. Rodríguez-Créixems, and E. Bouza. 1998. Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin. Infect. Dis. 26:535-536.